Martin Anlauf
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 30
- Oncology top 1%
- Lung Cancer Research Studies 34
- Pancreatic and Hepatic Oncology Research 21
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances 61
- Gastroenterology top 2%
-
- Pancreatic function and diabetes 10
- Adrenal and Paraganglionic Tumors 4
-
- Metabolism, Diabetes, and Cancer 5
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Günter KlöppelAurel PerrenEberhard WeihePaul KomminothBertram WiedenmannÉric BaudinLee E. EidenAnne Couvelard
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Martin Anlauf
91 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Neurology 2.0k
- Oncology 2.7k
- Epidemiology 3.0k
- Gastroenterology 199
- Endocrinology, Diabetes and Metabolism 497
Countries citing papers authored by Martin Anlauf
This map shows the geographic impact of Martin Anlauf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Anlauf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Anlauf more than expected).
Fields of papers citing papers by Martin Anlauf
This network shows the impact of papers produced by Martin Anlauf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Anlauf. The network helps show where Martin Anlauf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Anlauf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 54 | |
| 2 | 2018 | 11 | |
| 3 | ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomasbreakdown → | 2016 | 403 |
| 4 | 2014 | 21 | |
| 5 | 2013 | 8 | |
| 6 | 2013 | 26 | |
| 7 | 2011 | 54 | |
| 8 | 2010 | 83 | |
| 9 | 2010 | 16 | |
| 10 | 2009 | 80 | |
| 11 | 2008 | 105 | |
| 12 | 2007 | 98 | |
| 13 | 2007 | 58 | |
| 14 | 2007 | 58 | |
| 15 | 2006 | 24 | |
| 16 | 2005 | 83 | |
| 17 | 2005 | 89 | |
| 18 | 2004 | 17 | |
| 19 | 1999 | 47 | |
| 20 | 1963 | 8 |
About Martin Anlauf
Martin Anlauf is a scholar working on Neurology, Oncology and Epidemiology, having authored 92 papers that have together received 4.3k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (61 papers), Lung Cancer Research Studies (34 papers), Neuroblastoma Research and Treatments (30 papers), Pancreatic and Hepatic Oncology Research (21 papers), Pancreatic function and diabetes (10 papers), Metabolism, Diabetes, and Cancer (5 papers), Adrenal and Paraganglionic Tumors (4 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Neurology (2.0k citations), Oncology (2.7k citations) and Epidemiology (3.0k citations). Martin Anlauf has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Günter Klöppel, Aurel Perren, Eberhard Weihe, Paul Komminoth, Bertram Wiedenmann, Éric Baudin, Lee E. Eiden, Anne Couvelard, Martin Schäfer and Wolfram Trudo Knoefel.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.